Related references
Note: Only part of the references are listed.Comparison of Two Gamma Interferon Release Assays and Tuberculin Skin Testing for Tuberculosis Screening in a Cohort of Patients with Rheumatic Diseases Starting Anti-Tumor Necrosis Factor Therapy
Dimitrios Vassilopoulos et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
W. G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Evaluation of Gamma Interferon Release Assays Using Mycobacterium tuberculosis Antigens for Diagnosis of Latent and Active Tuberculosis in Mycobacterium bovis BCG-Vaccinated Populations
Shu Zhang et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
I. Solovic et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Risk of Tuberculosis Is Higher With Anti-Tumor Necrosis Factor Monoclonal Antibody Therapy Than With Soluble Tumor Necrosis Factor Receptor Therapy The Three-Year Prospective French Research Axed on Tolerance of Biotherapies Registry
F. Tubach et al.
ARTHRITIS AND RHEUMATISM (2009)
High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-γ release assay among HIV-infected individuals in BCG-vaccinated area
Weimin Jiang et al.
BMC IMMUNOLOGY (2009)
Positive Conversion of Tuberculin Skin Test and Performance of Interferon Release Assay to Detect Hidden Tuberculosis Infection During Anti-Tumor Necrosis Factor Agent Trial
Jeong Ha Park et al.
JOURNAL OF RHEUMATOLOGY (2009)
Anakinra for Rheumatoid Arthritis: A Systematic Review
Marty Mertens et al.
JOURNAL OF RHEUMATOLOGY (2009)
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update
Madhukar Pai et al.
ANNALS OF INTERNAL MEDICINE (2008)
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Reactivation of pulmonary tuberculosis in a patient with rheumatoid arthritis during treatment with IL-1 receptor antagonists (Anakinra)
Lucas D. Settas et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2007)
Attenuated response to purified protein derivative in patients with rheumatoid arthritis:: study in a population with a high prevalence of tuberculosis
DP de León et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
J Askling et al.
ARTHRITIS AND RHEUMATISM (2005)
Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2004)
The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis
M Feldmann et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2004)
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor
AK Mohan et al.
CLINICAL INFECTIOUS DISEASES (2004)
Interferonn assays-γ in the immunodiagnosis of tuberculosis:: a systematic review
M Pai et al.
LANCET INFECTIOUS DISEASES (2004)
Granulomatous infections due to tumor necrosis factor blockade: Correction
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2004)
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report
JJ Gómez-Reino et al.
ARTHRITIS AND RHEUMATISM (2003)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial
J Braun et al.
LANCET (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
